Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2026-01-02 @ 11:42 PM
Study NCT ID:
NCT05048056
Status:
TERMINATED
Last Update Posted:
2025-02-26
First Post:
2021-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis
Sponsor:
Akesobio Australia Pty Ltd
Organization: